GATA-3 inhibitors for use in the treatment of Th2-driven asthma

• 收藏
• 分享

专利权人:

Sterna Biologicals GmbH & Co.KG

发明人:

Bille, Joachim,Renz, Jonas

申请号：

AU2016264772

公开号：

AU2016264772A1

申请日:

2016.05.12

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

The invention relates to GATA-3 inhibitors for use in the treatment of Th2-driven asthma, in particular to DNAzymes directed at GATA-3 for use in the treatment of a patient suffering from allergic asthma, wherein the patient is characterized by (i) a blood eosinophil count of 3% or more, particularly of 4% or more, more particularly of 5% or more； and/or (ii) blood eosinophil count of 350 x 10

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/